Paradigms on Immunotherapy Combinations with Chemotherapy

Checkpoint inhibitors are being added to standard-of-care chemotherapy in multiple clinical trials. Success has been reported in non-small and small cell lung carcinomas and urothelial, head and neck, gastric, and esophageal cancers, and promising results are already available in triple-negative bre...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer discovery 2021-06, Vol.11 (6), p.1353-1367
Hauptverfasser:	Salas-Benito, Diego, Pérez-Gracia, José L, Ponz-Sarvisé, Mariano, Rodriguez-Ruiz, María E, Martínez-Forero, Iván, Castañón, Eduardo, López-Picazo, José M, Sanmamed, Miguel F, Melero, Ignacio
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use Drug Synergism Drug Therapy, Combination Humans Immune Checkpoint Inhibitors - administration & dosage Immune Checkpoint Inhibitors - therapeutic use Neoplasms - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!